MIACH Orthopaedics, a bioengineered surgical implant company, completed $22.5 million in financing.

UC San Diego researchers derived spinal cord neural stem cells from human pluripotent stem cells transplanted  into a rat model with spinal cord injury, according to a study in Nature Methods.

University of Toledo (Ohio) researchers developed a smart injectable calcium phosphate bone cement for orthopedic and spinal fusion applications. The smart CaP compositions were biocompatible, according to a study in Materials.

Best in Class Care entered an agreement with Regenexx to reduce high-cost musculoskeletal surgeries and accelerate employers' ability to directly contract with its network of providers.

The Seattle Regenerative Medicine Center opened a new location in Bellevue, Wash.

Baxter International received FDA clearance for its Actifuse Flow bone graft substitute.

Mark Mikhael, MD, is studying the use of proteins from donor stem cells in spinal fusion surgery, Chicago Health reports.

Market analysts predict the spine biologics market will top $2.6 billion by 2022, growing at a 4.4 percent compound annual growth rate, according to a Market Research Engine report.

SpinalCyte received a U.S. patent for its cartilage repair technology using an in vivo bioreactor.

While the use of biologics in spine surgery is still emerging, more spine surgeons are gaining exposure to the field as new clinical trials and noninvasive treatments are born.

InVivo Therapeutics released the 12-month results of its investigational study of the Neuro-Spinal Scaffold to treat acute thoracic complete spinal cord injury.

Avista Healthcare Public Acquisition will merge with the regenerative medicine company Organogenesis.

Isto Biologics is an orthobiologics company that develops spine and orthopedic solutions.

Axial spondyloarthritis patients who received biologics-based treatment had less work and activity impairment than patients who did not receive biologics, according to a study in the Annals of the Rheumatic Diseases.

Dr. Jonathan Hopper joined Vericel Corp., as the company's new CMO.

The global spine biologics market is expected to grow at a 4.4 percent compound annual growth rate to reach more than $2.6 billion by 2022, according to a Market Research Engine report.

Paragon 28 released its bone graft harvesting system, which is designed to improve foot and ankle surgical outcomes.

BioRestorative Therapies' study, which evaluates the benefits of long-term hypoxic culturing of human bone marrow-dervied mesenchymal stem cells to treat disc and spine diseases, was published in the Journal of Translational Medicine.

The Steadman Philippon Research Institute's fourth annual Vail Scientific Summit is Aug. 19-21 in Vail, Colo., and it will focus on the clinical advances made in the study of biologics and cell therapy.

Minneapolis-based University of Minnesota researchers used 3D-printing technology to print stem cell-infused scaffolds that may be implanted in spinal cords to alleviate nerve damage, the StarTribune reports.